Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive myoclonic epilepsy.

Mary L Zupanc1, Benjamin Legros

  • 1Department of Neurology and Pediatrics, Children's Hospital of Wisconsin, Milwaukee, Wisconsin, USA.

Cerebellum (London, England)
|November 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consciousness Monitoring and Outcome Prediction Using EEG Connectivity in Severe Traumatic Brain Injury.

Journal of neurotrauma·2026
Same author

Added Prognostic Value of EEG Reactivity in Comatose Patients Following Cardiac Arrest.

Annals of clinical and translational neurology·2026
Same author

Prolonged postictal deficit: Uncomplicated Todd's palsy or nonconvulsive status epilepticus?

Epilepsia·2026
Same author

Response of early status epilepticus to benzodiazepines in chronic benzodiazepine users: A case-control study.

Epilepsia·2026
Same author

Modified 2HELPS2B Score Predicts Failure to Wean From Anesthetics in Refractory and Super-Refractory Status Epilepticus.

Neurology. Clinical practice·2025
Same author

Features, Outcome, and Treatment of Postanoxic Status Epilepticus: Pooled Analysis of 3 Cohorts.

Neurology·2025
Same journal

From Proof-of-Concept to Decision-Grade Cerebellar Neurostimulation: A Precision-and-Governance Pipeline for Globally Scalable Balance Interventions.

Cerebellum (London, England)·2026
Same journal

Adult-Onset SCAR4 with a 30-Year Slowly Progressive Course: First Combined Assessment with FDG-PET and Brain Perfusion SPECT.

Cerebellum (London, England)·2026
Same journal

Clinical and Radiological Variability in Episodic Ataxia Type 2: A Case Report and Review of the Literature.

Cerebellum (London, England)·2026
Same journal

Trends and Disparities in Mortality from Hereditary Ataxia in United States, 2000-2020: A Retrospective Analysis with Projections to 2050.

Cerebellum (London, England)·2026
Same journal

Phenotype and Genetics of Spinocerebellar Ataxia Type 27B: Novel Movement-disorder Features, Cognitive Impairment, and Repeat Expansion Findings.

Cerebellum (London, England)·2026
Same journal

Clinical and Genetic Characteristics of SCA27B: A Global Systematic Review and Meta-Analysis.

Cerebellum (London, England)·2026
See all related articles

Progressive myoclonic epilepsies (PMEs) are rare neurological disorders. This review details common PME causes, aiding clinicians in diagnosis and treatment.

Area of Science:

  • Neurology
  • Genetics
  • Rare Diseases

Background:

  • Progressive myoclonic epilepsies (PMEs) encompass a group of rare, debilitating neurological disorders.
  • Key features include recurrent seizures, myoclonus (involuntary muscle jerks), and progressive decline in neurological function.

Purpose of the Study:

  • To provide clinicians with comprehensive information on the epidemiology, genetics, pathology, clinical presentation, and diagnostic/treatment strategies for common PMEs.
  • To enhance the diagnosis and management of these rare conditions.

Main Methods:

  • Review of current literature on the most common causes of PME.
  • Discussion encompasses Unverricht-Lundborg Disease, MERRF, neuronal ceroid lipofuscinosis, dentatorubropallidoluysan atrophy, Gaucher disease, Lafora disease, and sialidosis.

Related Experiment Videos

Main Results:

  • Detailed descriptions of the clinical and genetic characteristics of various PMEs.
  • Information on diagnostic tools, including EEG, and therapeutic approaches.

Conclusions:

  • Accurate diagnosis and timely management are crucial for improving outcomes in PME patients.
  • This review serves as a clinical resource for healthcare professionals managing rare epilepsy syndromes.